Demand for HPAPIs is rising as more companies opt for the benefits presented by lower dosage forms. Accessing specialized facilities with HPAPI handling capabilities is crucial to ensure the safe development and manufacturing of these drug substances.
Are you interested in applying innovative green technologies to enhance bioavailability? Explore how utilizing technologies such as AI and digital twinning can inform decision-making at the R&D stage and how to optimize the delivery of the final drug product with greener logistics.
Glioblastoma multiforme (GBM), the most common type of malignant primary brain tumor, is difficult to treat and has a high risk of recurrence after surgery. Discover new possibilities for increased dosing capabilities and diffusion across the brain parenchyma offered by nanoformed APIs.
Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential. Using our knowledge of nanomaterials science and specialized nanoformation expertise, Nanoform can help you to deliver a formulation that meets your needs.
